Social networks
1,648 318 14,315Activities
Technologies
Entity types
Location
201 Haskins Way, South San Francisco, CA 94080, USA
South San Francisco
United States of America
Employees
Scale: 51-200
Estimated: 131
Engaged corporates
1Added in Motherbase
2 years, 5 months agoLeading the Next Frontier of Cell Therapy
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.
cell therapy and autoimmune disease
Developing living cell therapies designed to restore balance to the immune system and ultimately cure autoimmune and inflammatory disease.